Introduction
============

Peptide α-thioesters are key intermediates for the convergent synthesis of proteins through native chemical ligation (NCL), a reaction that has revolutionized the field.[@cit1] While peptide thioesters can be directly synthesized through Boc-based solid-phase peptide synthesis (SPPS), their access *via* the more widely used Fmoc-based strategy is not straightforward due to the instability of the thioester moiety to repeated piperidine treatments used for Fmoc deprotection. Most Fmoc-based methodologies developed to date rely on a post-SPPS conversion of a piperidine-stable precursor into a thioester, but despite considerable efforts, no universal strategy has emerged.[@cit2] Thanks to their simple implementation, methods such as Dawson\'s *N*-acylurea (Nbz)[@cit3] and Liu\'s hydrazides[@cit4] for the generation of thioester precursors have recently become popular, but are still associated with several limitations.[@cit5] Thus, a reliable and straightforward route to peptide α-thioesters *via* Fmoc-SPPS is highly desirable.

A number of strategies based on β- or γ-mercapto amide thioesterification devices have recently appeared that exploit an amide-to-thioester rearrangement[@cit6],[@cit7] ([Fig. 1A](#fig1){ref-type="fig"}), which is reminiscent of the first step of intein-promoted *in vivo* protein splicing.[@cit8] In most cases, the *N* → *S* acyl shift is reversible and requires acidic conditions to proceed efficiently, meaning that the peptides have to be first converted into thioesters prior to NCL, which is optimal at pH ∼ 7. A few systems, referred to as crypto-thioesters, are able to operate under NCL conditions, thus enabling one-pot reactions (thioester formation and NCL). Cysteine-prolyl esters (CPEs) developed by Aimoto[@cit7d] ([Fig. 1B-b](#fig1){ref-type="fig"}) rely on an elegant intramolecular *O* → *N* shift to displace the amide--thioester equilibrium under NCL conditions, but with slow ligation kinetics. Although simple to implement, the α-methyl cysteine crypto-thioesters recently introduced by Offer[@cit7j] ([Fig. 1B-e](#fig1){ref-type="fig"}) are impaired by similarly slow kinetics. In both cases, the limiting factor is likely the disfavored *trans*-to-*cis* isomerization of the amide bond to generate the geometrically feasible intramolecular attack of the thiolate. Use of *N*,*N*-disubstituted β-mercapto amides can overpass this limitation by disfavoring the unproductive *trans* conformer. The symmetrical bis-sulfanylethylamides (SEAs, [Fig. 1B-c](#fig1){ref-type="fig"}) introduced by Melnyk[@cit7g] and Liu[@cit7h] can be used in NCL at pH 6--7 with relatively fast kinetics, but work better at lower pH. Otaka\'s *N*-sulfanylethylanilides[@cit7e] (Sealides, [Fig. 1B-d](#fig1){ref-type="fig"}) exploit the electronic effect of the anilide to enhance the electrophilicity of the amide bond. They are efficient NCL substrates at neutral pH only when using a phosphate-based buffer, probably arising from pseudo-intramolecular acid--base catalysis, but the exact mechanism remains elusive.[@cit9] Interestingly, while we were preparing this paper, a method appeared based on an *N*-ethyl cysteine device featuring a free carboxylic acid; peptides equipped with this device can act as crypto-thioesters. The α-acid group was shown to accelerate the reaction compared to an α-amide-containing analogue, with optimum ligation kinetics at pH 5.5, but with very slow kinetics at pH 7.[@cit10]

![*N* → *S* shift-based *in situ* synthesis of peptide thioesters for NCL. (A) Mechanism. (B) Crypto-thioesters bearing thioesterification devices operating under NCL conditions.](c5sc02630j-f1){#fig1}

We herein report the design and optimization of a simple and general methodology based on an *N*-(2-hydroxybenzyl)cysteine device, which can be automatically assembled in the solid-phase using inexpensive commercially available materials. Peptides bearing this device show fast *N* → *S* shift kinetics under NCL conditions around neutral pH, likely arising from a biomimetic intein-like intramolecular catalysis mechanism. The synthesis of these novel crypto-thioesters is straightforward and does not require an additional step prior to NCL. We believe that this accessible and robust Fmoc-based thioesterification device provides a significant advance to chemical protein synthesis.

Results and discussion
======================

We based our design on *N*-alkyl cysteine[@cit7c] as a scaffold for the design of our thioesterification device, as it can be readily assembled in the solid-phase from inexpensive and commercially available materials.[@cit11] However, its *N* → *S* shift is usually very slow at neutral pH,[@cit12] preventing its direct use in NCL. We focused our efforts on addressing this challenge by taking inspiration from the mechanism of *in vivo* protein splicing promoted by class 1 inteins. The first step of this process consists of a self-catalyzed *N* → *S* acyl shift of an amine into a thioester,[@cit8] where a highly conserved histidine residue plays a pivotal role. This *N*-protonated His is believed to catalyze C--N bond scission through polarization and then protonation of the nitrogen leaving group ([Fig. 2A](#fig2){ref-type="fig"}).[@cit13] We reasoned that the *N*-alkyl group of cysteine could be functionalized by an appropriate intramolecular proton donor able to mimic the catalytic histidine side chain, resulting in a much faster *N* → *S* shift at neutral pH. Accordingly, we designed an *N*-(2-hydroxybenzyl)cysteine device ([Fig. 2B](#fig2){ref-type="fig"}) leading to a hypothetical thermodynamically favored six-membered transition state for intramolecular *N*-protonation. The key to this design is a phenol group with a p*K*~a~ close to neutral, as this would result in a low energy cost for the intramolecular proton transfer at pH 7.

![Rational design of *N*-(2-hydroxybenzyl)cysteine thioesterification devices. (A) Mechanism of the intein self-catalyzed *N* → *S* shift in water. (B) Bio-inspired putative mechanism for the self-catalysis of the *N* → *S* shift in *N*-acyl-*N*-(2-hydroxybenzyl)cysteine peptides in water. (C) Mechanism of the intramolecular *O* → *N* shift in organic solvents shared by *N*-Hmb peptides and the new *N*-(2-hydroxybenzyl)cysteine thioesterification devices. PG: protecting group.](c5sc02630j-f2){#fig2}

We expected an additional advantage from the 2-hydroxybenzyl group: acceleration of *N*-acylation *via O*-acylation followed by the intramolecular *O* → *N* shift ([Fig. 2C](#fig2){ref-type="fig"}), as in the *N*-acylation of 2-hydroxy-5-methoxybenzyl (Hmb) protected amines.[@cit14] This could overcome a common drawback encountered with most *N* → *S* acyl shift-based thioesterification devices developed so far, the difficult *N*-acylation of a secondary amine,[@cit7g],[@cit7h],[@cit15] to introduce the first residue of the peptide sequence.

Optimization of the hydroxybenzyl group
---------------------------------------

Three different *N*-2-hydroxybenzyl groups were introduced on a solid supported cysteine derivative through an automated reductive amination protocol (compounds **2a--c**) and were compared with a reference *N*-ethyl cysteine device (**2d**). For this preliminary study, a reporter peptide (LYRAG-NH~2~) was introduced C-terminal to cysteine to facilitate the analysis using LC-MS after TFA-mediated deprotection and cleavage from the resin. Excellent results were obtained with the 2-hydroxy-5-nitrobenzyl (Hnb) group,[@cit16] giving quantitative *N*-acylation yields for a Gly residue under mild amide coupling conditions (HBTU/HOBt) ([Table 1](#tab1){ref-type="table"}, entry 5), while the ethyl-substituted compound ([Table 1](#tab1){ref-type="table"}, entry 7) was unreactive. Hmb or unsubstituted 2-hydroxybenzyl groups ([Table 1](#tab1){ref-type="table"}, entries 1 and 3) showed only moderate assistance. These results are in line with the literature:[@cit16] Alewood and collaborators already observed the much superior acyl transfer efficiencies of 2,6- and 2,5-Hnb compared to Hmb. Moreover, the p*K*~a~ of the hydroxyl group of Hnb is close to 7 (∼6.5, see ESI, Fig. S11[†](#fn1){ref-type="fn"}), in line with our requirements discussed above for efficient biomimetic catalysis. We accordingly selected *N*-Hnb-Cys as our preferred scaffold.

###### Screening of different *N*-(2-hydroxybenzyl) groups for their ability to enhance the *N*-acylation yield of a solid-supported *S*-trityl-protected *N*-substituted cysteine. PS: polystyrene

  ![](c5sc02630j-u1.jpg){#ugr1}                                                                       
  ------------------------------- -------- ------------------------------------------------- -------- -------------------------------------------
  1                               **2a**   HBTU/HOBt                                         **3a**   \<5[^*c*^](#tab1fnc){ref-type="table-fn"}
  2                               **2a**   HATU                                              **3a**   45[^*c*^](#tab1fnc){ref-type="table-fn"}
  3                               **2b**   HBTU/HOBt                                         **3b**   11
  4                               **2b**   HATU                                              **3b**   12
  5                               **2c**   HBTU/HOBt                                         **3c**   \>99
  6                               **2c**   HATU                                              **3c**   \>99
  7                               **2d**   HBTU/HOBt                                         **3d**   \<1
  8                               **2d**   HATU                                              **3d**   12
  9                               **2d**   PyBrop                                            **3d**   1
  10                              **2d**   HATU/DMAP[^*d*^](#tab1fnd){ref-type="table-fn"}   **3d**   13

^*a*^All reactions were conducted for 2 h, in DMF, using 10 equiv. Fmoc-Xaa-OH, 9.5 equiv. coupling agent and 20 equiv. iPr~2~NEt.

^*b*^Yields determined after TFA-mediated cleavage of the peptide resin using HPLC analysis of the amine-to-amide conversion.

^*c*^Estimated yields due to closely eluting HPLC peaks.

^*d*^0.1 equiv. DMAP.

Optimization of the thiol protecting group of cysteine and linkage to the resin
-------------------------------------------------------------------------------

When exploring the scope of peptides bearing our *N*-Hnb-Cys thioesterification device, we observed an instability upon purification and storage due to a premature spontaneous *N* → *S* shift. Fortunately, the protection of the cysteine thiol as an S-S*t*Bu disulfide, stable to Fmoc-SPPS and readily removed under NCL conditions,[@cit17] resolved this problem (see ESI, pS24--S29[†](#fn1){ref-type="fn"}).[@cit18] As the use of a reporter peptide was no longer needed at this point, we looked at introducing Cys(S*t*Bu) as either the α-acid or the amide, using a Wang-type or a Rink\'s amide linker, respectively. Disappointingly, in the former case we were confronted with Cys epimerization[@cit19] and β-elimination, followed by the addition of piperidine.[@cit20] In the latter case, we observed a TFA-catalyzed hydrolysis[@cit21] reaction, leading to a mixture of amide-(**7**) and acid-terminated (**8**) compounds (see ESI pS27--S29[†](#fn1){ref-type="fn"} for details). Simple incorporation of a Gly spacer between the Rink\'s linker and the device solved these problems. Preliminary evaluation of NCL reactions with the model cysteinyl peptide **6** showed that this additional residue (compound **9**) did not affect the NCL kinetics compared to cysteine α-amide **7**, the reaction being even slightly faster than for the α-acid **8** (ESI, Fig. S57[†](#fn1){ref-type="fn"}). As expected, cysteine deprotection was very fast, showing the complete removal of the S*t*Bu group within minutes.

Study of the *N*-acylation of the device
----------------------------------------

*N*-Acylation of the optimized device was then examined for the twenty proteogenic amino acids, using a standard SPPS protocol ([Table 2](#tab2){ref-type="table"}). In most cases the coupling yields were good to excellent. No significant epimerization was observed, except for Fmoc-Cys(Trt) (7%), which is well known for its propensity for racemization.[@cit22] Six residues showed modest *N*-acylation yields (\<50%). In these difficult cases, we looked at further optimizing the coupling, avoiding the use of sensitive or costly reagents, and keeping in mind an easy-to-automate procedure. Three successive couplings of Fmoc-Ser(*t*Bu) resulted in an excellent yield (85%, entry 16). The five-fold coupling of the more demanding Fmoc-Val led to a good 65% yield (entry 21). Alternatively, single coupling under microwave heating at 70 °C led to an excellent 92% yield for Fmoc-Val (entry 22) and 78% for Fmoc-Ile (entry 24). Importantly, the unreacted secondary amine could be quantitatively capped by acetylation, giving a byproduct that can be readily removed during the peptide precipitation step following TFA-based cleavage from the resin.[@cit23]

###### Acylation of the resin **4** with the 20 different protected proteogenic amino acids under automated coupling conditions. TG: Tentagel

  ![](c5sc02630j-u2.jpg){#ugr2}                              
  ------------------------------- ------------- -------- --- ------------------------------------------
  1                               Gly           **5a**   1   97
  2                               Asp(O*t*Bu)   **5b**   1   94
  3                               Ala           **5c**   1   90
  4                               Glu(O*t*Bu)   **5d**   1   89[^*d*^](#tab2fnd){ref-type="table-fn"}
  5                               Cys(Trt)      **5e**   1   86[^*e*^](#tab2fne){ref-type="table-fn"}
  6                               Met           **5f**   1   85
  7                               Asn(Trt)      **5g**   1   80[^*f*^](#tab2fnf){ref-type="table-fn"}
  8                               His(Trt)      **5h**   1   77
  9                               Phe           **5i**   1   77
  10                              Gln(Trt)      **5j**   1   72
  11                              Leu           **5k**   1   71
  12                              Trp(Boc)      **5l**   1   69
  13                              Arg(Pbf)      **5m**   1   67
  14                              Tyr(*t*Bu)    **5n**   1   58
  15                              Ser(*t*Bu)    **5o**   1   49
  16                              Ser(*t*Bu)    **5o**   3   85
  17                              Lys(Boc)      **5p**   1   45
  18                              Thr(*t*Bu)    **5q**   1   19
  19                              Pro           **5r**   1   19
  20                              Val           **5s**   1   16
  21                              Val           **5s**   5   65
  22                              Val           **5s**   1   92[^*g*^](#tab2fng){ref-type="table-fn"}
  23                              Ile           **5t**   1   12
  24                              Ile           **5t**   1   78[^*g*^](#tab2fng){ref-type="table-fn"}

^*a*^Reactions were conducted at a 0.025 mmol scale using a Prelude synthesizer at RT for 30 min in NMP/DMF 5 : 1, using 10 equiv. Fmoc-Xaa-OH, 9.5 equiv. HCTU and 20 equiv. iPr~2~NEt.

^*b*^When indicated, the coupling step was repeated under the same conditions.

^*c*^Yields determined after TFA-mediated cleavage of the peptidyl resin and subsequent HPLC analysis of the amine-to-amide conversion.

^*d*^Concomitant formation of pyroglutamate during TFA cleavage.

^*e*^93 : 7 mixture of [l]{.smallcaps}-Cys/[d]{.smallcaps}-Cys.

^*f*^Incomplete deprotection of the Trt group.

^*g*^Coupling at 70 °C.

Mechanistic insights
--------------------

Next, we wanted to assess the validity of our intein-inspired design hypothesis that should result in the self-catalysis of the *N* → *S* shift at neutral pH through intramolecular protonation. Here, we synthesized a model peptide equipped with a 2-methoxy-5-nitrobenzylcysteine device (**12**), designed to inhibit the acid--base properties of the phenol group while not being expected to lead to major changes in terms of steric hindrance compared to Hnb (peptide **9**). We were delighted to see that the hydroxyl group very efficiently catalyzes the *N* → *S* acyl shift: \>50-fold rate enhancement of NCL was measured for **9** compared to **12** under the NCL conditions ([Fig. 3](#fig3){ref-type="fig"}), supporting our hypothesis.[@cit24]

![NCL of the model crypto-thioester peptides **7--11** bearing an *N*-Hnb-cysteine device, and an analog (**12**) with the hydroxyl group masked as a methyl ether. ^*a*^ 300 mM MPAA, pH 6.6, 50 °C. ^*b*^ Hnb methyl ether (**12**).](c5sc02630j-f3){#fig3}

Moreover, the ligation of **9** at different pH values showed the *N* → *S* acyl shift/NCL process to be fastest at pH ∼ 6.5, and slightly slower at lower pH (ESI, Fig. S67[†](#fn1){ref-type="fn"}). This fits with the p*K*~a~ of the Hnb group (6.5), suggesting the need for a subtle balance between the phenol group protonation and the thiol group deprotonation (cysteine p*K*~a~ ∼ 8.5) in influencing the *N* → *S* shift. To eliminate a possible *N* → *O* shift mechanism, the thiol was protected with a stable acetamidomethyl (Acm) group (**13**). This NCL-unreactive compound confirms the crucial role of the SH group and provides further data to suggest an intramolecular *N* → *S* shift mechanism. Critically, this latter finding also highlights the potential of the *N*-Hnb-Cys thioester precursors for successive ligations in the N-terminus-to-C-terminus (N-to-C) direction. We are currently evaluating latent crypto-thioesters that could be activated by deprotection of a NCL-stable cysteine protecting group, as has been exploited for related *N*-methyl Cys,[@cit11],[@cit25] CPE,[@cit26] SEA[@cit17] and Sealide[@cit27] thioester precursors.

Study of the NCL with model peptides
------------------------------------

Next, we turned our attention to the effectiveness of our new thioesterification device in NCL reactions for a range of thioesters bearing different amino acids C-terminal to the *N*-Hnb-Cys device ([Fig. 3](#fig3){ref-type="fig"}). Note that we used relatively dilute conditions for the peptide reactants (∼1 mM) and low concentrations of the 4-mercaptophenylacetic acid catalyst (MPAA, 25 mM).[@cit28] Relatively fast NCL kinetics were observed using Ala (peptide **9**) and Ser (**10**) crypto-thioesters, as the reactions were complete after 24 h at 37 °C. For comparison with the NCL kinetics data available in the literature, we determined the apparent second order kinetic constants, with results in the 0.03--0.06 M^--1^ s^--1^ range, in line with the reported values for standard NCL with preformed thioesters.[@cit29] These data validate the rapid *N* → *S* shift promoted by our device. Ligation at valine (crypto-thioester **11**) was 10 times slower, as we had anticipated from the steric hindrance of its side chain.[@cit30] However, increasing the MPAA concentration to 300 mM, lowering the pH close to the optimum (6.6) and heating to 50 °C led to kinetics comparable to Ala and Ser crypto-thioesters. The latter result suggests that the method could be applied in routine NCL even for peptide sequences known to be kinetically demanding.

Potential epimerization during the *N* → *S*-shift/NCL process was rigorously examined by synthesizing a [d]{.smallcaps}-Ala-containing product (**15**) as an HPLC standard. Only trace epimerization (\<0.4%) was detected in the crude NCL mixture starting from the [l]{.smallcaps}-Ala crypto-thioester **9**. We also examined the hydrolysis of the crypto-thioesters into the corresponding acids. All reactions were clean and did not show significant amounts of hydrolysis (\<4% for **9** after 24 h and using excess crypto-thioester).

Application of the methodology to two cysteine-rich peptides
------------------------------------------------------------

Importantly, our new method was applied to the synthesis of two long naturally-occurring cysteine-rich peptide sequences, MT7 and Cg-BigDef1. Muscarinic toxin 7 (MT7), 65 residues, was isolated from green mamba venom.[@cit31] MT7 naturally forms a three-finger-fold stabilized by four disulfide bonds. Big defensin 1 (Cg-BigDef1) is a 93-residue host-defense peptide isolated from Japanese oysters and is composed of a hydrophobic N-terminal domain and a β-defensin-like cationic C-terminal domain containing six cysteine residues involved in three disulfide bridges.[@cit32]

These two peptide sequences were chosen as challenging examples to demonstrate the applicability of our methodology, as their syntheses *via* the NCL of two segments require long thioesters, 41 and 56 amino acids, respectively. In addition, the N-terminal Cg-BigDef1 domain is a "difficult sequence",[@cit33]*i.e.* hard to synthesize using Fmoc-SPPS.[@cit34] Both of the crypto-thioesters (**18** and **21**) were synthesized and purified in good yields (13% and 7%, see ESI, pS86 and S93[†](#fn1){ref-type="fn"}). The two ligations were complete overnight at 1 and 2 mM concentrations, respectively, and showed clean HPLC profiles ([Fig. 4](#fig4){ref-type="fig"}). Finally, pure reduced forms of MT7 (**20**) and Cg-BigDef1 (**23**) were isolated after HPLC purification in 14% and 18% yields, respectively[@cit35] (ESI, Fig. S85 and S93[†](#fn1){ref-type="fn"}), demonstrating the utility of the *N*-Hnb-Cys method.

![Application of the *N*-(2-hydroxy-5-nitrobenzyl)cysteine thioesterification device to the NCL-based syntheses of two long and demanding peptide sequences.](c5sc02630j-f4){#fig4}

Conclusions
===========

In conclusion, we introduced a novel C-terminal thioesterification device, *N*-Hnb-Cys(S*t*Bu), that can rapidly rearrange into a thioester at neutral pH, allowing its use in NCL even under demanding conditions. Fast kinetics likely result from an internal catalysis mechanism provided by a well-positioned phenol moiety arising from a bio-inspired intein-like design. Synthesis from inexpensive commercially available materials and further peptide elongation are straightforward, and can be fully automated on a peptide synthesizer without requiring a post-synthetic step, thus constituting a major advance in the field. Applicability of the strategy was demonstrated by the synthesis of two long naturally occurring cysteine-rich peptide sequences. Further work is ongoing in our laboratory for its application to other synthetically demanding targets.
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